In a report released yesterday, Josh Jennings from TD Cowen maintained a Buy rating on Stryker, with a price target of $435.00.
Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Josh Jennings has given his Buy rating due to a combination of factors, including Stryker’s strong performance in recent quarters and the expectation of continued momentum. The company has consistently demonstrated robust growth, with a notable 10.1% organic growth in the first quarter, which adjusted for a selling day headwind, translates to approximately 11.1%.
Despite a projected slowdown in growth to 8.8% for the second quarter, Stryker is positioned against one of its easier comparisons from 2024. The company has a history of achieving double-digit growth even against challenging benchmarks, suggesting that current market estimates are well-founded. This consistent ability to outperform expectations supports the Buy rating.
In another report released on July 16, Bank of America Securities also maintained a Buy rating on the stock with a $450.00 price target.